Abstract 2276: Preclinical development and mechanism of action studies of NM21-1480, a PD-L1/4-1BB/HSA trispecific MATCH3 therapeutic clinical candidate
Snell, Daniel, Gunde, Tea, Warmuth, Stefan, Lichtlen, Peter, Tietz, Julia, Brock, Matthias, Simonin, Alexandre, Hess, Christian, Christopher, Weinert, Heiz, Robin, Flueckiger, Naomi, Zeberer, Julia, Diem, Dania, Mahler, Dana, Morenzoni, Diego, Wickihalder, Belinda, Muntwiler, Simone, Poelderl, Antonia, Kuettner, Benjamin, Wagen, Sandro, Meyer, Sebastian, Egan, Timothy, Urech, David
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Short Peptides Allowing Preferential Detection of Candida albicans Hyphae
Kaba, Hani E. J, Pölderl, Antonia, Bilitewski, Ursula
Published in Analytical chemistry (Washington) (01.09.2015)
Published in Analytical chemistry (Washington) (01.09.2015)
Get full text
Journal Article